Home > News > Arrowhead Completes Warrant Redemption
June 16th, 2005
Arrowhead Completes Warrant Redemption
Abstract:
The net proceeds of over $20 million in cash will be used to fund the Company's subsidiaries, the Company's research projects and general working capital purposes.
Source:
businesswire
Related Links |
Arrowhead Research Corporation
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||